Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease

Interstitial lung disease (ILD) refers to a heterogeneous group of diseases characterized by lung fibroblast proliferation, interstitial inflammation, and fibrosis-induced lung damage. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is known to be activated by pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Rongxiu, Guo, Qianyu, Hu, Junping, Li, Na, Gao, Rui, Mi, Liangyu, Zhang, Zhaoliang, Liu, Hechao, Guo, Zhiying, Zhao, Hanxi, Zhang, Liyun, Xu, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985822/
https://www.ncbi.nlm.nih.gov/pubmed/35400994
http://dx.doi.org/10.2147/DDDT.S353494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985822/
https://www.ncbi.nlm.nih.gov/pubmed/35400994
http://dx.doi.org/10.2147/DDDT.S353494

Ejemplares similares